HERON THERAPEUTICS, INC. /DE/ (HRTX) Total liabilities 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) total liabilities at each fiscal year-end, per SEC filings.
$241.5MFY2025 · since FY2016: $88.7M → $241.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $241.5M | -9.5% |
| FY2024 | $266.8M | +4.0% |
| FY2023 | $256.5M | +8.0% |
| FY2022 | $237.4M | +4.1% |
| FY2021 | $228.1M | +94.9% |
| FY2020 | $117.1M | +7.5% |
| FY2019 | $108.9M | +18.4% |
| FY2018 | $92.0M | -10.8% |
| FY2017 | $103.2M | +16.3% |
| FY2016 | $88.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice